Amorvet Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 20 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Profit Growth 51.47%
- Ebitda 51.47%
- Net Worth 6.93%
- Total Assets 6.61%
About Amorvet
Amorvet Private Limited (APL) is a Private Limited Indian Non-Government Company incorporated in India on 17 May 2004 and has a history of 20 years and eight months. Its registered office is in Delhi, India.
The Corporate was formerly known as H Pal Softech Private Limited. The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Anuj Arora, Manish Arora, and Neha Arora serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U15100DL2004PTC126447
-
Company No.
126447
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 May 2004
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Amorvet?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anuj Arora
|
Director | 09-Oct-2009 | Current |
|
Manish Arora
|
Director | 09-Oct-2009 | Current |
|
Neha Arora
|
Additional Director | 08-May-2024 | Current |
Financial Performance of Amorvet.
Amorvet Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 51.47% increase in profit. The company's net worth moved up by a moderate rise of 6.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amorvet?
In 2023, Amorvet had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Arosol Chemicals Private LimitedAnuj Arora, Manish Arora and 1 more are mutual person
-
Alphafacts Health Solutions Private LimitedAnuj Arora and Neha Arora are mutual person
-
Argano Organic Limited
Anuj Arora, Manish Arora and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Amorvet?
Unlock and access historical data on people associated with Amorvet, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amorvet, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amorvet's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
